Page 55 - AN-2-2

Advanced Neurology Seizures and CKD

Parathyroid Day in Chronic Kidney Disease. Clin Kidney J, Nephrol Hypertens, 25: 100–106.
12: 269–280.
https://doi.org/10.1097/MNH.0000000000000205
https://doi.org/10.1093/ckj/sfy061
63. Petrea RE, O’Donnell A, Beiser AS, et al., 2020, Mid to late
52. Bühler G, Balabanova S, Milowski S, et al., 1997, Detection life hypertension trends and cerebral small vessel disease in
of immunoreactive parathyroid hormone-related protein in the Framingham Heart Study. Hypertension, 76: 707–714.
human cerebrospinal fluid. Exp Clin Endocrinol Diabetes, https://doi.org/10.1161/HYPERTENSIONAHA.120.15073
105: 336–340.
64. Biose IJ, Dewar D, Macrae IM, et al., 2020, Impact of
https://doi.org/10.1055/s-0029-1211775 stroke co-morbidities on cortical collateral flow following
53. Weinstein R, 2001, Hypocalcemic toxicity and atypical ischaemic stroke. J Cereb Blood Flow Metab, 40: 978–990.
reactions in therapeutic plasma exchange. J Clin Apher, https://doi.org/10.1177/0271678X19858532
16: 210–211.
65. Sprick JD, Nocera JR, Hajjar I, et al., 2020, Cerebral blood
https://doi.org/10.1002/jca.10000 flow regulation in end-stage kidney disease. Am J Physiol
54. Gibbs R, Macnaughton P, 2007, Electrolyte and metabolic Ren Physiol, 319: F782–F791.
disturbances in critically ill patients. Anaesth Intensive Care, https://doi.org/10.1152/ajprenal.00438.2020
8: 529–533.
66. Claassen JA, Thijssen DH, Panerai RB, et al., 2021, Regulation
https://doi.org/10.1016/j.mpaic.2007.09.015 of cerebral blood flow in humans: Physiology and clinical
55. Gungor O, Aydin Z, Inci A, et al., 2021, Seizures in patients implications of autoregulation. Physiol Rev, 101: 1487–1559.
with kidney diseases: A neglected problem? Nephrol Dial https://doi.org/10.1152/physrev.00022.2020
Transplant, 38: 291–299.
67. Mauritz M, Hirsch LJ, Camfield P, et al., 2022, Acute
https://doi.org/10.1093/ndt/gfab283 symptomatic seizures: An educational, evidence‐based
56. Abdelmalik PA, Shannon P, Yiu A, et al., 2007, Hypoglycemic review. Epileptic Disord, 24: 26–49.
seizures during transient hypoglycemia exacerbate https://doi.org/10.1684/epd.2021.1376
hippocampal dysfunction. Neurobiol Dis, 26: 646–660.
68. Fugate JE, Rabinstein AA, 2015, Posterior reversible
https://doi.org/10.1016/j.nbd.2007.03.002 encephalopathy syndrome: Clinical and radiological
57. Halawa I, Zelano J, Kumlien E, 2015, Hypoglycemia and risk manifestations, pathophysiology, and outstanding questions.
of seizures: A retrospective cross-sectional study. Seizure, Lancet Neurol, 14: 914–925.
25: 147–149. https://doi.org/10.1016/S1474-4422(15)00111-8
https://doi.org/10.1016/j.seizure.2014.10.005 69. Fugate JE, Claassen DO, Cloft HJ, et al., 2010, Posterior
58. Hahr AJ, Molitch ME, 2015, Management of diabetes reversible encephalopathy syndrome: Associated clinical
mellitus in patients with chronic kidney disease. Clin and radiologic findings. Mayo Clin Proc, 85: 427–432.
Diabetes Endocrinol, 1: 2. https://doi.org/10.4065/mcp.2009.0590
https://doi.org/10.1186/s40842-015-0001-9 70. Fischer M, Schmutzhard E, 2017, Posterior reversible
59. Brick JF, Gutrecht JA, Ringel RA, 1989, Reflex epilepsy encephalopathy syndrome. J Neurol, 264: 1608–1616.
and nonketotic hyperglycemia in the elderly: A specific https://doi.org/10.1007/s00415-016-8377-8
neuroendocrine syndrome. Neurology, 39: 394.
71. Agarwal R, 2018, Mechanisms and mediators of hypertension
https://doi.org/10.1212/WNL.39.3.394 induced by erythropoietin and related molecules. Nephrol
60. Santos PC, Krieger JE, Pereira AC, 2012, Renin-angiotensin Dial Transplant, 33: 1690–1698.
system, hypertension, and chronic kidney disease: https://doi.org/10.1093/ndt/gfx324
Pharmacogenetic implications. J Pharmacol Sci, 120: 77–88.
72. Strippoli GF, Craig JC, Manno C, et al., 2004, Hemoglobin
https://doi.org/10.1254/jphs.12r03cr targets for the anemia of chronic kidney disease: A meta-
61. Kopecky C, Lytvyn Y, Domenig O, et al., 2019, Molecular analysis of randomized, controlled trials. J Am Soc Nephrol,
regulation of the renin-angiotensin system by sodium- 15: 3154–3165.
glucose cotransporter 2 inhibition in Type 1 diabetes https://doi.org/10.1097/01.ASN.0000145436.09176.A7
mellitus. Diabetologia, 62: 1090–1093.
73. Mahmoud SH, Zhou XY, Ahmed SN, 2020, Managing
https://doi.org/10.1007/s00125-019-4871-8 the patient with epilepsy and renal impairment. Seizure,
76: 143–152.
62. Zhou L, Liu Y, 2016, Wnt/β-catenin signaling and renin-
angiotensin system in chronic kidney disease. Curr Opin https://doi.org/10.1016/j.seizure.2020.02.006

29
https://doi.org/10.36922/an.314
Volume 2 Issue 2 (2023) olume 2 Issue 2 (2023)
V 29 https://doi.org/10.36922/an.314